Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00103883 · ClinicalTrials.gov registry record
A Novel Method to Determine HIV Incidence Among Youth
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 440
- Enrollment target
NCT00103883 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 440 participants.
The verdict
NCT00103883 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 440 participants
- Enrollment target
Study Summary
Identifying young people with early HIV-1 infection is important for increasing linkage to care, for behavioral counseling, and for enrolling individuals into programs that can provide effective interventions to disease progression and improve outcome. This study will develop and evaluate a saliva-based sensitive/less sensitive (S/LS) assay for differentiating persons with recent HIV-1 infection (less than 133 days) from those with established HIV-1 infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2003-02 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00103883
The ClinicalTrials.gov registry entry for NCT00103883 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00103883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00103883 about?
NCT00103883 is a clinical study titled "A Novel Method to Determine HIV Incidence Among Youth". Identifying young people with early HIV-1 infection is important for increasing linkage to care, for behavioral counseling, and for enrolling individuals into programs that can provide effective interventions to disease progression and improve outcome. This study will develop and evaluate a saliva-b...
What is the current status of trial NCT00103883?
This trial is currently completed. The enrollment target is 440 participants. The study started on 2003-02. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00103883?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.